期刊文献+

不同分子亚型乳腺癌组织中CD44^+/CD24^(-/low)细胞的分布情况及临床意义 被引量:3

Distribution of CD44^+/CD24^-/low cells in different molecular subtypes of breast cancer tissues and its clinical significance
下载PDF
导出
摘要 目的研究具有干细胞样特征的CD44^+/CD24^(-/low)细胞群在不同分子亚型乳腺癌组织中的分布水平及临床意义。方法采用双标免疫组化在199例乳腺癌组织中同时检测CD44、CD24的表达情况,分析CD44、CD24在不同分子亚型乳腺癌组织中的表达差异及其与临床病理特征及预后的相关性。结果CD44、CD24分别在Luminal A型(82.5%)和HER2过表达型(69.0%)乳腺癌组织中阳性率较高;CD44^+/CD24^(-/low)表型与患者年龄(P=0.0444)、有无淋巴结转移(P=0.0377)相关。结论CD44在Luminal A型乳腺癌组织中高表达,CD24在不同分子亚型乳腺癌组织中表达无差异;CD44^+/CD24^(-/low)表型在不同分子亚型乳腺癌组织中表达无差异,与乳腺癌患者淋巴结转移密切相关,是独立于乳腺癌分子分型之外的影响乳腺癌淋巴结转移的因素。 Objective To investigate the distribution of CD44^+/CD24^-/lowcells in different molecular subtypes of breast cancer tissues and its clinical significance.Methods The expression of CD44 and CD24 in 199 breast cancer tissues was simultaneously detected by double-staining immunohistochemistry.The association of CD44 and CD24 expression in different molecular types of breast cancer tissues with clinical pathological characteristics and prognosis was analyzed.Results The positive rates of CD44 and CD24 were higher in breast cancer tissues of subtypes Luminal A(82.5%)and HER2 overexpression(69.0%),respectively.The phenotype of CD44^+/CD24^-/lowwas associated with patient age(P=0.0444),and the presence of lymph node metastasis(P=0.0377).Conclusions CD44 is highly expressed in breast cancer tissues of type Luminal A.No statistical difference was found in CD24 expression among different molecular subtypes of breast cancer tissues.There was no statistical difference in CD44^+/CD24^-/lowphenotype among different molecular subtypes of breast cancer tissues.Meanwhile,CD44^+/CD24^-/lowis closely associated with lymph node metastasis,which suggests that CD44^+/CD24^-/lowis an influencing factor of lymph node metastasis independent of the molecular types of breast cancer.
作者 李玉冰 向臣希 殷倩倩 马东慎 吴婉娜 倪慧敏 刘慧 LI Yubing;XIANG Chenxi;YIN Qianqian;MA Dongshen;WU Wanna;NI Huimin;LIU Hui(Department of Pathology,Xuzhou Medical University,Xuzhou,Jiangsu 221004,China;Department of Pathology,the Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu 221002)
出处 《徐州医科大学学报》 CAS 2021年第1期17-21,共5页 Journal of Xuzhou Medical University
关键词 CD44 CD24 乳腺癌 分子亚型 CD44 CD24 breast cancer molecular subtype
  • 相关文献

参考文献4

二级参考文献11

  • 1Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance [J]. Nat Rev Cancer,2005,5(4) :275 -84.
  • 2Donnenberg V S, Donnenberg A D. Multiple drug resistance in cancer revisited:the cancer stemecell hypothesis [ J ]. J Clin Phar.maco1,2005,45 ( 8 ) :872 - 7.
  • 3Phillips T M, McBride W H, Pajonk F. The response of CD24-/low/CD44 + breast cancer-initiating cells to radiation [ J]. Nad Cancer Inst ,2006,98 (4) : 1777 - 85.
  • 4Mylona E, Giannopoulou I, Fasomytakis E, et al. The clinico- pathologic and prognostic significance of CIM4+/CD24-/low and CD44-/CD24+tumor cells in invasive breast carcinomas [ J ]. Hum Patho1,2008,39 (7) : 1096 - 102.
  • 5Honeth G, Bendahl P O, Ringner M, et al. The CD44 +/CD24 - phenotype is enriched in basal-like breast tumors [ J ]. Breast Canc- er Res ,2008, 10 (3) : R53.
  • 6Lim S C, Oh S H. The role of CD24 in various human epithelial neoplasias [ J]. Pathol Res Pract,2005,201 (7) :479 - 86.
  • 7Bircan S, Kapucuoglu N, Baspinar S, et al. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study [ J ]. Pathol Res Pract, 2006,202(8) :569 -76.
  • 8AI-Hajj M, W icha M S, Benito Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci USA ,2003,100 (7) :3983 - 8.
  • 9林帅,吴诚义.乳腺癌中CD44^+/CD24^-表型及乳腺癌分子亚型的分布及意义[J].临床与实验病理学杂志,2010,26(3):289-292. 被引量:8
  • 10章青波,卢玫瑰,徐宝福,王拴,赵丽,周巧霞,严赫,王超群,黄飞骏.乳腺浸润性导管癌中CD44、TRIM24、TAGLN-2、ER、PR的表达及其临床意义[J].临床与实验病理学杂志,2017,33(7):724-727. 被引量:7

共引文献34

同被引文献26

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部